<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="effect of human adipose tissue-derived mesenchymal stem cells (AdMSCs) on" exact="atopic dermatitis" post="(AD) in the BALB/c mouse model. The AdMSCs attenuated"/>
 <result pre="of human adipose tissue-derived mesenchymal stem cells (AdMSCs) on atopic" exact="dermatitis" post="(AD) in the BALB/c mouse model. The AdMSCs attenuated"/>
 <result pre="level, amount of histamine released, and prostaglandin E2 level. Atopic" exact="dermatitis" post="increased the expression levels of cytokines/chemokines, such as interleukin-5"/>
 <result pre="of MIP-2 attenuated the clinical symptoms associated with AD. Atopic" exact="dermatitis" post="increased the expression levels of hallmarks of allergic inflammation,"/>
 <result pre="T cell transcription factors in AD was also investigated. Atopic" exact="dermatitis" post="increased the expression levels of T-bet and GATA-3 [transcription"/>
 <result pre="from regulating the expression of T-bet, GATA-3, and Foxp3. Atopic" exact="dermatitis" post="increased the expression of cluster of differentiation 163 (CD163),"/>
 <result pre="for the anti-atopic effects of AdMSCs. adipose tissue-derived stem cells" exact="atopic dermatitis" post="targets of stem cells cellular interactions MIP-2 miR-122a-5p SOCS1"/>
 <result pre="the anti-atopic effects of AdMSCs. adipose tissue-derived stem cells atopic" exact="dermatitis" post="targets of stem cells cellular interactions MIP-2 miR-122a-5p SOCS1"/>
 <result pre="cells can ameliorate allergic diseases such as asthma, rhinitis, and" exact="dermatitis" post="( Nemeth et al., 2010; Kavanagh and Mahon, 2011;"/>
 <result pre="attenuate inflammation and promote tissue homeostasis in the course of" exact="allergic asthma" post="( Urbanek et al., 2016). In addition, MSCs can"/>
 <result pre="inflammation and promote tissue homeostasis in the course of allergic" exact="asthma" post="( Urbanek et al., 2016). In addition, MSCs can"/>
 <result pre="inflammation and airway remodeling via PI3K/Akt signaling pathway in rat" exact="asthma" post="model ( Lin et al., 2015), and ameliorate allergic"/>
 <result pre="to intensify the immunomodulatory effects of MSCs, and it decreases" exact="allergic contact dermatitis" post="(ACD) ( Zhang et al., 2017). Human umbilical cord"/>
 <result pre="intensify the immunomodulatory effects of MSCs, and it decreases allergic" exact="contact dermatitis" post="(ACD) ( Zhang et al., 2017). Human umbilical cord"/>
 <result pre="the immunomodulatory effects of MSCs, and it decreases allergic contact" exact="dermatitis" post="(ACD) ( Zhang et al., 2017). Human umbilical cord"/>
 <result pre="2. Induction of Atopic Dermatitis in BALB/c Mice Symptoms of" exact="atopic dermatitis" post="(AD) were induced by using DNCB, as previously described"/>
 <result pre="Induction of Atopic Dermatitis in BALB/c Mice Symptoms of atopic" exact="dermatitis" post="(AD) were induced by using DNCB, as previously described"/>
 <result pre="mesenchymal stem cells (AdMSCs) attenuate the clinical symptoms associated with" exact="atopic dermatitis" post="(AD). (A) 2, 4-dinitro chlorobenzene (DNCB) was employed to"/>
 <result pre="stem cells (AdMSCs) attenuate the clinical symptoms associated with atopic" exact="dermatitis" post="(AD). (A) 2, 4-dinitro chlorobenzene (DNCB) was employed to"/>
 <result pre="with slight modifications ( Eom et al., 2014b). Rat basophilic" exact="leukemia" post="(RBL2H3) cells were obtained from the Korea Cell Line"/>
 <result pre="group was subjected to cytokine array analysis (Figure 3B). Atopic" exact="dermatitis" post="increased the expression levels of IL-5, IL-17, chemokine (C-C"/>
 <result pre="AD induced by DNCB in BALB/c mice (Figure 4A). Atopic" exact="dermatitis" post="increased the serum IgE level, the amount of histamine"/>
 <result pre="and ß-hexosaminidase activity in an MIP-2-dependent manner (Figure 4B). Atopic" exact="dermatitis" post="increased the expression levels of SOCS1, TGaseII, COX-2, histone"/>
 <result pre="4C). Therefore, AD and anaphylaxis display common molecular features. Atopic" exact="dermatitis" post="induced epidermal hyperplasia and lymphocyte infiltration. It also increased"/>
 <result pre="activity associated with 3′ UTR of SOCS1 in rat basophilic" exact="leukemia" post="(RBL2H3) cells ( Noh et al., 2017). Since miR-122a-5p,"/>
 <result pre="symptoms associated with AD in BALB/c mice (Figure 6B). Atopic" exact="dermatitis" post="increased the expression levels of MIP-2, COX-2, HDAC3, and"/>
 <result pre="BALB/c mice under AD without or with siSOCS1 injection. Atopic" exact="dermatitis" post="increased the expression of CXCL13 in the sera of"/>
 <result pre="amount of histamine released in BALB/c mouse (Figure 10E). Atopic" exact="dermatitis" post="increased the expression levels of CD163, SOCS1, MIP-2, COX-2,"/>
 <result pre="expression of iNOS in a CXCL13-dependent manner (Figure 11A). Atopic" exact="dermatitis" post="increased the number of degranulated MCs in a CXCL13-dependent"/>
 <result pre="AdMSCs might attenuate AD by regulating T cell responses. Atopic" exact="dermatitis" post="increased the expression levels of T-bet and GATA-3 but"/>
 <result pre="cytokines. In addition to this, IL-17 represents Th17 cells. Atopic" exact="dermatitis" post="increased the expression levels of IL-4, IL-13, IL-6, IL-17,"/>
 <result pre="of RORγT, a specific transcription factor of Th17 cells. Atopic" exact="dermatitis" post="decreased the expression of IL-10 in BALB/c mouse in"/>
 <result pre="conditioned medium. (B) Same as (A) except that rat basophilic" exact="leukemia" post="cells, equivalent of mouse mast cells, were employed. Western"/>
 <result pre="et al., 2018). The conditioned medium of AdMSCs can promote" exact="endometrial cancer" post="growth and invasion ( Chu et al., 2018). These"/>
 <result pre="al., 2018). The conditioned medium of AdMSCs can promote endometrial" exact="cancer" post="growth and invasion ( Chu et al., 2018). These"/>
 <result pre="Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate" exact="atopic dermatitis." post="Stem Cell Res. Ther. 9: 187. 10.1186/s13287-018-0939-5 29996938 Cho"/>
 <result pre="Intratracheal administration of adipose derived mesenchymal stem cells alleviates chronic" exact="asthma" post="in a mouse model. BMC Pulm. Med. 18: 131."/>
 <result pre="of a Th1 transcriptome response in a murine model of" exact="allergic asthma." post="PLoS One 4: e8172. 10.1371/journal.pone.0008172.45 20027288 Dong C. Virtucio"/>
 <result pre="Kang H. K. et al. ( 2015). Docosahexaenoic acid alleviates" exact="atopic dermatitis" post="by generating tregs and IL-10/TGF-β-modified macrophages via a TGF-β-dependent"/>
 <result pre="H. K. et al. ( 2015). Docosahexaenoic acid alleviates atopic" exact="dermatitis" post="by generating tregs and IL-10/TGF-β-modified macrophages via a TGF-β-dependent"/>
 <result pre="umbilical cord blood-derived mesenchymal stem cells in a murine ovalbumin" exact="asthma" post="model. Clin. Exp. Allergy 47 937– 945. 10.1111/cea.12920 28294434"/>
 <result pre="Axelrod D. Capitle E. Rameshwar P. ( 2012). Tolerance-like mediated" exact="suppression" post="by mesenchymal stem cells in patients with dust mite"/>
 <result pre="Suppressive effects of mesenchymal stem cells in adipose tissue on" exact="allergic contact dermatitis." post="Ann. Dermatol. 29 391– 399. 10.5021/ad.2017.29.4.391 28761285 Kim H."/>
 <result pre="effects of mesenchymal stem cells in adipose tissue on allergic" exact="contact dermatitis." post="Ann. Dermatol. 29 391– 399. 10.5021/ad.2017.29.4.391 28761285 Kim H."/>
 <result pre="inflammation and allergic inflammation-promoted enhanced tumorigenic and metastatic potential of" exact="cancer" post="Cells. J. Biol. Chem. 290 14245– 14266. 10.1074/jbc.M115.645580 25907560"/>
 <result pre="stem cells suppress lung inflammation and airway remodeling in chronic" exact="asthma" post="rat model via PI3K/Akt signaling pathway. Int. J. Clin."/>
 <result pre="2015). The asian AD phenotype combines features of AD and" exact="psoriasis" post="with increased TH17 polarization. J. Allergy Clin. Immunol. 136"/>
 <result pre="( 2014). MicroRNA-146a alleviates chronic skin inflammation in AD through" exact="suppression" post="of innate immune responses in keratinocytes. J. Allergy Clin."/>
 <result pre="( 2018). Prostaglandin E2 stimulates adaptive IL-22 production and promotes" exact="allergic contact dermatitis." post="J. Allergy Clin. Immunol. 141 152– 162. 10.1016/j.jaci.2017.04.045 28583370"/>
 <result pre="2018). Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic" exact="contact dermatitis." post="J. Allergy Clin. Immunol. 141 152– 162. 10.1016/j.jaci.2017.04.045 28583370"/>
 <result pre="Wang S. Y. et al. ( 2016). MicroRNAs involved in" exact="asthma" post="after mesenchymal stem cells treatment. Stem Cells Dev. 25"/>
</results>
